BIOMILQ, Inc. Secures $21M to Further Its Mission to Produce Sustainable Lab-Grown Breastmilk

North Carolina-based mammary biotechnology company BIOMILQ, Inc., proudly announces the successful close of $21 million in Series A financing, which will enable their acceleration of bringing cell-cultured human milk to market. Leading the fundraise are Danish life science investor Novo Holdings and..

https://www.biomilq.com/po...